NDC 61919-588
Lidocaine 50 mg per 1 g patch
On the label: Direct Rx. It's repackaged: Direct Rx rebottles it from Par Health USA, LLC's NDC 0603-1880.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Teikoku Seiyaku Co.,ltd. | Higashikagawa, Japan | Makes it | No problems foundFeb 14, 2025 · 5 inspections |
Repackaging site
- Direct Rx, Dawsonville, GA, United States · relabels it
Recalls
- Apr 13, 2022 · Class II · Mckesson Medical-Surgical Inc. Corporate Office
cGMP deviations: Temperature abuse
Lots: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Lidocaine: every company that makes it
- Form
- patch, cutaneous
- Strength
- 50 mg per 1 g
- Approval
- NDA authorized generic NDA020612
- On the market since
- May 12, 2020
- Package NDCs
61919-588-30- Official label
- DailyMed (National Library of Medicine), updated Mar 17, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?